The non-contrast CT imaging market size is projected to be worth US$ 226.5 million in 2023. The market is likely to surpass US$ 347.5 million by 2033 at a CAGR of 4.4% during the forecast period. The non-contrast CT imaging market refers to the market for computed tomography (CT) imaging procedures that do not require the use of contrast agents. CT imaging is a medical imaging technique that combines X-ray technology with computer processing to generate detailed cross-sectional images of the body.
Non-contrast CT imaging involves performing CT scans without the administration of contrast agents, which are substances used to enhance the visibility of certain structures or abnormalities in the body. Contrast agents are typically used in CT imaging to highlight blood vessels, organs, tumors, or other areas of interest that may be difficult to visualize without enhancement.
Other Drivers Propelling the Demand for Non-Contrast CT Imaging include:
Challenges for Companies /Manufacturers in the Non-Contrast CT Imaging Market:
Opportunities in the Non-Contrast CT Imaging Industry:
Latest Trends in the Non-Contrast CT Imaging Market:
| Attributes | Details |
|---|---|
| Non-Contrast CT Imaging Market Size (2023) | US$ 226.5 million |
| Non-Contrast CT Imaging Market Projected Size (2033) | US$ 347.5 million |
| Value CAGR (2023 to 2033) | 4.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global non-contrast CT imaging market experienced a CAGR of 2.9%, reaching a market size of US$ 226.5 million in 2023.
From 2017 to 2022, the demand for non-contrast CT imaging has been driven by several factors, including the increasing prevalence of various medical conditions, advancements in imaging technology, and the need for quick and accurate diagnostic procedures. Non-contrast CT imaging is considered safe, cost-effective, and relatively quick compared to other imaging modalities, making it a popular choice in many clinical settings.
Future Forecast for Non-Contrast CT Imaging Industry:
Looking ahead, the global non-contrast CT imaging industry is expected to rise at a CAGR of 4.4% from 2023 to 2033. During the forecast period, the market size is expected to reach US$ 347.5 million by 2033.
Non-contrast CT imaging refers to computed tomography scans performed without the use of contrast agents or dyes. It is commonly used in various medical applications, including the evaluation of brain, abdomen, pelvis, and renal conditions. Non-contrast CT imaging provides valuable diagnostic information and helps in the detection of abnormalities, such as tumors, kidney stones, and vascular diseases.
| Country | The United States |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 146.7 million |
| CAGR % 2023 to End of Forecast (2033) | 6.8% |
The non-contrast CT imaging industry in the United States is expected to reach a market size of US$ 146.7 million by 2033, expanding at a CAGR of 6.8%. Non-contrast CT imaging is considered a cost-effective and efficient diagnostic tool for certain indications. It allows for quick imaging and evaluation of structures without the need for contrast agents, reducing procedure time and associated costs. This cost-effectiveness, along with the ease of use and widespread availability of CT scanners, has contributed to the growth of the non-contrast CT imaging market.
| Country | The United Kingdom |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 23.2 million |
| CAGR % 2023 to End of Forecast (2033) | 5.1% |
The non-contrast CT imaging industry in the United Kingdom is expected to reach a market value of US$ 23.2 million, expanding at a CAGR of 5.1% during the forecast period. The UK's National Health Service (NHS) plays a crucial role in driving the adoption and growth of medical imaging technologies. The NHS's focus on providing quality healthcare services and timely diagnostics has led to investments in advanced imaging technologies, including non-contrast CT. Funding and support from the NHS facilitate the availability and accessibility of non-contrast CT imaging services across the country.
| Country | China |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 43.8 million |
| CAGR % 2023 to End of Forecast (2033) | 7.6% |
The non-contrast CT imaging industry in China is anticipated to reach a market size of US$ 43.8 million, moving at a CAGR of 7.6% during the forecast period. China's rapid urbanization and the development of healthcare infrastructure in tier-2 and tier-3 cities have improved access to medical services, including non-contrast CT imaging. The expansion of healthcare facilities, including hospitals and imaging centers, in these areas has contributed to the growth of the market.
| Country | Japan |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 21.0 million |
| CAGR % 2023 to End of Forecast (2033) | 5.6% |
The non-contrast CT imaging industry in Japan is estimated to reach a market size of US$ 21.0 million by 2033, thriving at a CAGR of 5.6%. Collaboration between academia, industry stakeholders, and healthcare providers in Japan has played a crucial role in the development and adoption of non-contrast CT imaging. Research institutions and medical facilities collaborate with industry partners to drive technological advancements, conduct clinical trials, and develop best practices. This collaboration promotes the growth of the non-contrast CT imaging market.
| Country | South Korea |
|---|---|
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 9.0 million |
| CAGR % 2023 to End of Forecast (2033) | 5.6% |
The non-contrast CT imaging industry in South Korea is expected to reach a market size of US$ 9.0 million, expanding at a CAGR of 5.6% during the forecast period. South Korea has become a popular destination for medical tourism, attracting patients from both domestic and international markets. The availability of advanced medical technologies, including non-contrast CT imaging, plays a significant role in attracting medical tourists. The growth of medical tourism has further stimulated the demand for non-contrast CT imaging services in South Korea.
Principal Consultant
Medium-Slice Scanner is expected to dominate the non-contrast CT imaging industry with a CAGR of 3.3% from 2023 to 2033. Medium-slice scanners provide better spatial resolution and image quality. Better anatomical structure visualization is made possible by this advancement, which also improves the precision of diagnostic interpretation-especially in non-contrast CT imaging. Medium-slice scanners are generally faster than older-generation scanners, allowing for quicker scan times. This is beneficial for both patients and healthcare providers, as it reduces the time required for image acquisition, enhancing patient comfort and increasing departmental efficiency.
The chest imaging segments are expected to dominate the non-contrast CT imaging industry with a CAGR of 2.8% from 2023 to 2033. Chest imaging, particularly non-contrast CT scans, is commonly used to evaluate and diagnose various respiratory conditions such as pulmonary embolism, pneumonia, lung nodules, interstitial lung diseases, and lung cancer. The demand for accurate and detailed chest imaging is driving the growth of non-contrast CT imaging.
The hospital segment is expected to dominate the non-contrast CT imaging industry with a CAGR of 3.3% from 2023 to 2033. Hospitals are the main sources of healthcare and frequently have departments for sophisticated imaging with non-contrast CT scanners. The use of non-contrast CT imaging has grown as a result of their wide distribution and accessibility to a sizable patient population. Non-contrast CT scans are conveniently accessible to patients through hospitals, facilitating rapid diagnosis and treatment.
The market for non-contrast CT imaging is highly competitive, with numerous vendors vying for supremacy. Important players must use cunning tactics in such a situation to stay ahead of the opposition.
Key Strategies Used by the Participants
To produce creative products that improve effectiveness, which is reliability, and cost-effectiveness, businesses make significant investments in research and development. Product innovation enables companies to stand out from the competition while also meeting the shifting needs of their customers.
Strategic partnerships and alliances with other businesses are regularly formed by Key players in an industry to take advantage of each other's advantages and expand their market reach. Through such partnerships, companies may also obtain access to new technologies and markets.
The market for non-contrast CT imaging devices is growing quickly in emerging economies like China and India. To increase their presence in these regions, major companies are expanding their distribution networks and building regional manufacturing sites.
Mergers and acquisitions are frequently used by key players in the non-contrast CT imaging business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Non-Contrast CT Imaging Market:
In 2023, the worldwide market value could reach US$ 226.5 million.
The overall market valuation is anticipated to reach nearly US$ 347.5 million by 2033.
The United States leads the global market and could be valued at US$ 146.7 million by 2033.
The growing demand in the United Kingdom at 5.1% may drive the Europe Market through 2033.
Cedars-Sinal, Siemens, and GE Healthcare are some top players in the global market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product Features/ USPs 4.3. Technological Roadmap 4.4. Installed Base Scenario 4.5. Reimbursement Scenario 4.6. Regulatory Landscape 4.7. PESTEL Analysis 4.8. Porter’s Analysis 4.9. Value Chain Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Key Player’s Historic Growth 5.2.2. Growing Cancer Prevalence 5.2.3. Favourable Government Regulations 5.2.4. Rising Demand for Neurology Imaging Solutions 5.2.5. Technological Advancement in the Devices 5.2.6. Increasing Prevalence of Cardiovascular Diseases 5.2.7. Frequency of Product Approvals 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Volume (in Units) Analysis, 2017 to 2022 6.2. Current and Future Volume (in Units) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 7. Global Market - Pricing Analysis 7.1. Regional Pricing Analysis By Product 7.2. Pricing Break-up 7.2.1. Manufacturer Level Pricing 7.2.2. Distributor Level Pricing 7.3. Global Average Pricing Analysis Benchmark 7.4. Pricing Assumptions 8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017 to 2022 and Forecast, 2023 to 2033 8.1. Historical Market Value (US$ Million) and Volume (Units) Analysis, 2017 to 2022 8.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 8.2.1. Y-o-Y Growth Trend Analysis 8.2.2. Absolute $ Opportunity Analysis 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Product, 2017 to 2022 9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Product, 2023 to 2033 9.3.1. Low-Slice Scanners 9.3.2. Medium-Slice Scanner 9.3.3. High-Slice Scanners 9.4. Market Attractiveness Analysis By Product 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022 10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033 10.3.1. Cardiac imaging 10.3.2. Oncology 10.3.3. Neurology 10.3.4. Chest Imaging 10.3.5. Abdominal and Pelvic Imaging 10.3.6. Others 10.4. Market Attractiveness Analysis By Application 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022 11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033 11.3.1. Hospitals 11.3.2. Diagnostic Imaging Centres 11.3.3. Ambulatory Imaging Centres 11.4. Market Attractiveness Analysis By End User 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022 12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. South Asia 12.3.5. East Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (Middle East & Africa) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 13.3.1. By Country 13.3.1.1. USA 13.3.1.2. Canada 13.3.2. By Product 13.3.3. By Application 13.3.4. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By Application 13.4.4. By End User 13.5. Country Level Analysis & Forecast 13.5.1. USA Market Analysis 13.5.1.1. Introduction 13.5.1.2. Market Analysis and Forecast by Market Taxonomy 13.5.1.2.1. By Product 13.5.1.2.2. By Application 13.5.1.2.3. By End User 13.5.2. Canada Market Analysis 13.5.2.1. Introduction 13.5.2.2. Market Analysis and Forecast by Market Taxonomy 13.5.2.2.1. By Product 13.5.2.2.2. By Application 13.5.2.2.3. By End User 13.6. Market Trends 13.7. Key Market Participants - Intensity Mapping 13.8. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Product 14.3.3. By Application 14.3.4. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Application 14.4.4. By End User 14.5. Country Level Analysis & Forecast 14.5.1. Brazil Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Application 14.5.1.2.3. By End User 14.5.2. Mexico Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Application 14.5.2.2.3. By End User 14.5.3. Argentina Market Analysis 14.5.3.1. Introduction 14.5.3.2. Market Analysis and Forecast by Market Taxonomy 14.5.3.2.1. By Product 14.5.3.2.2. By Application 14.5.3.2.3. By End User 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. France 15.3.1.3. Italy 15.3.1.4. UK 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. BENELUX 15.3.1.8. Rest of Europe 15.3.2. By Product 15.3.3. By Application 15.3.4. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Application 15.4.4. By End User 15.5. Country Level Analysis & Forecast 15.5.1. Germany Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Application 15.5.1.2.3. By End User 15.5.2. France Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Application 15.5.2.2.3. By End User 15.5.3. Italy Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Application 15.5.3.2.3. By End User 15.5.4. UK Market Analysis 15.5.4.1. Introduction 15.5.4.2. Market Analysis and Forecast by Market Taxonomy 15.5.4.2.1. By Product 15.5.4.2.2. By Application 15.5.4.2.3. By End User 15.5.5. Spain Market Analysis 15.5.5.1. Introduction 15.5.5.2. Market Analysis and Forecast by Market Taxonomy 15.5.5.2.1. By Product 15.5.5.2.2. By Application 15.5.5.2.3. By End User 15.5.6. Russia Market Analysis 15.5.6.1. Introduction 15.5.6.2. Market Analysis and Forecast by Market Taxonomy 15.5.6.2.1. By Product 15.5.6.2.2. By Application 15.5.6.2.3. By End User 15.5.7. BENELUX Market Analysis 15.5.7.1. Introduction 15.5.7.2. Market Analysis and Forecast by Market Taxonomy 15.5.7.2.1. By Product 15.5.7.2.2. By Application 15.5.7.2.3. By End User 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Product 16.3.3. By Application 16.3.4. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Application 16.4.4. By End User 16.5. Country Level Analysis & Forecast 16.5.1. India Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Application 16.5.1.2.3. By End User 16.5.2. Thailand Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Application 16.5.2.2.3. By End User 16.5.3. Indonesia Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Application 16.5.3.2.3. By End User 16.5.4. Malaysia Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Application 16.5.4.2.3. By End User 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.2. By Product 17.3.3. By Application 17.3.4. By End User 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Application 17.4.4. By End User 17.5. Country Level Analysis & Forecast 17.5.1. China Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Application 17.5.1.2.3. By End User 17.5.2. Japan Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Application 17.5.2.2.3. By End User 17.5.3. South Korea Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Application 17.5.3.2.3. By End User 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 18.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Product 18.3.3. By Application 18.3.4. By End User 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Application 18.4.4. By End User 18.5. Country Level Analysis & Forecast 18.5.1. Australia Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Application 18.5.1.2.3. By End User 18.5.2. New Zealand Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Application 18.5.2.2.3. By End User 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Market Taxonomy, 2017 to 2022 19.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. Türkiye 19.3.1.3. Northern Africa 19.3.1.4. South Africa 19.3.1.5. Rest of Middle East and Africa 19.3.2. By Product 19.3.3. By Application 19.3.4. By End User 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Application 19.4.4. By End User 19.5. Country Level Analysis & Forecast 19.5.1. GCC Countries Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Application 19.5.1.2.3. By End User 19.5.2. Türkiye Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Application 19.5.2.2.3. By End User 19.5.3. Northern Africa Market Analysis 19.5.3.1. Introduction 19.5.3.2. Market Analysis and Forecast by Market Taxonomy 19.5.3.2.1. By Product 19.5.3.2.2. By Application 19.5.3.2.3. By End User 19.5.4. South Africa Market Analysis 19.5.4.1. Introduction 19.5.4.2. Market Analysis and Forecast by Market Taxonomy 19.5.4.2.1. By Product 19.5.4.2.2. By Application 19.5.4.2.3. By End User 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Market Structure Analysis 20.1. Market Analysis by Tier of Companies 20.2. Market Share Analysis of Top Players 20.3. Market Presence Analysis 21. Competition Analysis 21.1. Competition Dashboard 21.2. Branding and Promotional Strategies, By Key Players 21.3. Key Development Analysis 21.4. Competition Deep Dive 21.4.1. Cedars-Sinai. 21.4.1.1. Overview 21.4.1.2. Product Portfolio 21.4.1.3. Key Financials 21.4.1.4. Sales Footprint 21.4.1.5. SWOT Analysis 21.4.1.6. Strategy Overview 21.4.1.6.1. Marketing Strategy 21.4.1.6.2. Product Strategy 21.4.1.6.3. Channel Strategy 21.4.2. Siemens Healthineers 21.4.2.1. Overview 21.4.2.2. Product Portfolio 21.4.2.3. Key Financials 21.4.2.4. Sales Footprint 21.4.2.5. SWOT Analysis 21.4.2.6. Strategy Overview 21.4.2.6.1. Marketing Strategy 21.4.2.6.2. Product Strategy 21.4.2.6.3. Channel Strategy 21.4.3. GE HealthCare 21.4.3.1. Overview 21.4.3.2. Product Portfolio 21.4.3.3. Key Financials 21.4.3.4. Sales Footprint 21.4.3.5. SWOT Analysis 21.4.3.6. Strategy Overview 21.4.3.6.1. Marketing Strategy 21.4.3.6.2. Product Strategy 21.4.3.6.3. Channel Strategy 21.4.4. Canon Medical Systems 21.4.4.1. Overview 21.4.4.2. Product Portfolio 21.4.4.3. Key Financials 21.4.4.4. Sales Footprint 21.4.4.5. SWOT Analysis 21.4.4.6. Strategy Overview 21.4.4.6.1. Marketing Strategy 21.4.4.6.2. Product Strategy 21.4.4.6.3. Channel Strategy 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Non-Contrast CT Imaging Market
